nature neurOSCIenCe a r t I C l e S Chronic neuropathic pain resulting from peripheral nerve injury can cause prolonged suffering and reduce quality of life in patients. Current treatments for neuropathic pain symptoms are poorly effective, owing to limited knowledge of the molecular mechanisms underlying the development of neuropathic pain. Nerve injury causes abnormal hyperactivity of primary sensory nerves 1,2 and enduring changes in the expression of pro-and antinociceptive genes in the DRG 3,4 . However, little is known about the mechanisms involved in the sustained alterations in gene transcription found in injured DRGs and their roles in neuropathic pain.
a r t I C l e S Chronic neuropathic pain resulting from peripheral nerve injury can cause prolonged suffering and reduce quality of life in patients. Current treatments for neuropathic pain symptoms are poorly effective, owing to limited knowledge of the molecular mechanisms underlying the development of neuropathic pain. Nerve injury causes abnormal hyperactivity of primary sensory nerves 1, 2 and enduring changes in the expression of pro-and antinociceptive genes in the DRG 3, 4 . However, little is known about the mechanisms involved in the sustained alterations in gene transcription found in injured DRGs and their roles in neuropathic pain.
One of the hallmarks of neuropathic pain is the long-lasting downregulation of many genes encoding K + channels, including Kcna4, Kcnd2, Kcnq2 and Kcnma1, in the injured DRG [5] [6] [7] [8] . These K + channels are crucially involved in controlling the membrane potential and excitability of DRG neurons [9] [10] [11] . K v 1.4 (encoded by Kcna4) and K v 4.2 (encoded by Kcnd2) primarily constitute the transient A-type K + current 10, 12 , whereas K v 7.2 (encoded by Kcnq2) mediates the M-current, which regulates resting membrane potential and neuronal excitability 9, 13 . Large-conductance Ca 2+ -activated K + channels (encoded by Kcnma1) are involved in the feedback inhibition of the action potential frequency and Ca 2+ influx 14, 15 . Two predominant epigenetic mechanisms are DNA methylation and histone tail modifications, which are key regulators of long-lasting changes in gene expression of postmitotic neurons 16, 17 . Histone modifications associated with transcriptionally inactive chromatin include histone deacetylation, H3K9me2 and H3K27me3, which are catalyzed by histone deacetylases (HDACs), the lysine dimethyltransferases G9a (encoded by Ehmt2) and G9a-like protein (GLP) and enhancer of zeste homolog-2 (EZH2), respectively 16, 18, 19 . It is not known whether DNA methylation and histone modifications have a function in the transcriptional silencing of K + channel genes in neuropathic pain.
In the present study, we investigated the epigenetic mechanism involved in K + channel gene silencing in the DRG after nerve injury. We selected Kcna4, Kcnd2, Kcnq2 and Kcnma1 as representative K + channel genes, because their expression influences the excitability of DRG neurons and pain sensitivity 6, 7, 11, 12, 20, 21 . We found that nerve injury consistently increased the enrichment of H3K9me2 in the promoters of Kcna4, Kcnd2, Kcnq2 and Kcnma1. G9a inhibition or ablation in the DRG restored K + channel expression and attenuated pain hypersensitivity. RNA sequencing analysis revealed that inhibition of G9a not only reactivated almost all K + channel genes silenced but also normalized the expression of many other genes altered by nerve injury. Thus, we uncovered a dominant role for G9a-mediated H3K9me2 in the transcriptional silencing associated with neuroplasticity in neuropathic pain. a r t I C l e S and reached a maximum 3 weeks after SNL, suggesting that K + channel expression in the DRG is suppressed during the transition from acute to chronic pain after nerve injury. We also found that the UCSC Genome Browser (https://genome.ucsc.edu/) does not annotate the correct transcriptional start sites (TSSs) for Kcna4. We identified a new upstream exon in the Kcna4 gene in the rat DRG (Supplementary Fig. 1 ). SNL had no effect on the mRNA levels of these four K + channels in dorsal spinal cords (Supplementary Fig. 2a ).
Nerve injury upregulates HDACs, G9a and EZH2 in DRGs
Increased activity of HDACs, G9a and EZH2 is associated with epigenetic gene silencing 18 . We therefore examined how nerve injury affects the expression of HDACs, G9a and EZH2. We selected two class I HDACs (HDAC1 and HDAC2) and two class II HDACs (HDAC4 and HDAC5), because these four HDACs are highly expressed in the nervous system 23 . Immunoblotting experiments indicated that concentrations of HDAC1, HDAC2, HDAC4, G9a and EZH2 were higher in injured DRGs 3 weeks after SNL than after sham surgery (Fig. 1b,c) . SNL substantially increased the levels of Hdac1, Hdac4, Ehmt2 and Ezh2 mRNA in the DRG ( Supplementary   Fig. 3a-f) . SNL had no effect on the level of Pcna mRNA, a cellular marker for proliferation, in the DRG (Supplementary Fig. 3g ).
To determine whether increased expression of HDACs, G9a and EZH2 is associated with an increase in their enzymatic activity, we measured the level of histone H3 acetylation, H3K9me2 and a r t I C l e S H3K27me3, which are the substrates of HDACs, G9a and EZH2, respectively. SNL decreased H3 acetylation and increased the H3K9me2 and H3K27me3 levels in the DRG (Fig. 1d,e) . SNL had no significant effect on the level of G9a and H3K9me2 in spinal cords ( Supplementary  Fig. 2b ). These data indicate that nerve injury increases the expression and activity of HDACs, G9a and EZH2 in the DRG.
To determine the cellular distribution of HDACs, G9a and EZH2 in the DRG, we performed double immunolabeling using the neuronal marker NeuN and HDAC1, HDAC2, HDAC4, HDAC5, G9a or EZH2. Confocal images showed that HDAC2, HDAC4, HDAC5, G9a and EZH2 were immunoreactive predominantly in DRG neurons (Fig. 2a,b,d-f) . However, HDAC1 was not expressed in DRG neurons (Fig. 2c) , which is consistent with in situ hybridization data showing that HDAC1 is expressed principally in glial cells 23 . Whereas G9a, HDAC2 and EZH2 were predominantly localized in the nucleus, HDAC4 and HDAC5 were present in both the nucleus and the cytoplasm in DRG neurons. SNL did not alter the cellular distribution of G9a, EZH2 or four HDACs in the DRG.
Nerve injury increases H3K9me2 at K + channel gene promoters Because the global activity of HDACs, G9a and EZH2 was increased in the injured DRG, we next determined whether nerve injury affects histone modifications at the promoter regions of Kcna4, Kcnd2, Kcnq2 and Kcnma1. We performed chromatin immunoprecipitation (ChIP) followed by quantitative PCR (ChIP-PCR). We selected two activating histone marks (H3K4me3 and H3K9ac) and two repressive histone marks (H3K9me2 and H3K27me3) 18 . We first validated the ChIP antibodies and optimized ChIP-PCR procedures using Gapdh, a highly expressed gene, and Slc12a5, which is poorly expressed in the DRG 24 , as controls. H3K4me3 and H3K9ac were highly enriched at the Gapdh promoter but poorly enriched in the Slc12a5 promoter. In contrast, the levels of H3K9me2 and H3K27me3 were very low at the Gapdh promoter and very high at the Slc12a5 promoter (Fig. 3a,b) . These data suggest that these four histone marks are predictive for gene expression in the DRG.
SNL consistently increased the occupancy of H3K9me2 at the promoters of all four genes encoding K + channels around their TSSs in the DRG (Fig. 3c-f) . SNL significantly reduced levels of H3 acetylated at Lys9 (H3K9ac) at the Kcna4 and Kcnma1 promoters and the H3K4me3 level at the Kcnd2 promoter region (Fig. 3c-f) . However, SNL did not affect H3K27me3 enrichment in any of these promoters. Further experiments showed increases in H3K9me2 enrichment in two additional promoter regions in each of the four genes in the injured DRG (Fig. 3g,h) a r t I C l e S of Kcna4, Kcnd2, Kcnq2 and Kcnma1 in the DRG is associated with altered histone modifications, particularly an increase in the enrichment of G9a-dependent H3K9me2. These findings support the idea that a closed chromatin structure contributes to nerve injury-induced transcriptional silencing of K + channel genes in the DRG.
SNL has no effect on methylation of K + channel gene promoters DNA methylation is another important epigenetic mechanism regulating gene expression 16 . Therefore, we investigated whether nerve injury-induced downregulation of Kcna4, Kcnd2, Kcnq2 and Kcnma1 are associated with changes in the DNA methylation patterns of these genes. Bisulfite sequencing data from sham rats showed that the promoter regions of Kcna4, Kcnd2, Kcnq2 and Kcnma1 in the DRG had little methylation. SNL had no significant effect on the DNA methylation status at the promoter regions of any of these genes in the DRG (Fig. 3i-l G9a is crucial in nerve injury-induced K + channel gene silencing We next determined whether inhibition of G9a, EZH2 or HDACs could increase expression levels of K + channels in the injured DRG. We used UNC0638 (10 µg), a highly selective G9a inhibitor 25 ; GSK503 (5 µg), a highly specific EZH2 inhibitor 26 ; and suberoylanilide hydroxamic acid (SAHA; 50 µg), a specific HDAC inhibitor 27 . The dosages of the inhibitors were selected on the basis of the dose-response effects in the in vivo behavioral experiments ( Supplementary Fig. 4a-f ) and efficacy and specificity data ( Supplementary Fig. 5 ). Because intrathecal injections bring agents in direct contact with DRG neurons 28, 29 , we treated animals with daily intrathecal injections for 8 d. As expected, intrathecal UNC0638 decreased the H3K9me2 protein level in the DRG. UNC0638 had no significant effect on levels of acetylated H3 and H3K27me3 but significantly increased levels of H3K9ac (P = 0.005) (Supplementary Fig. 5e,f) . Notably, the G9a inhibitor BIX-01294 also increases H3K9ac levels in the rat brain 30 , which suggests a close association between G9a and HDACs at H3K9. We determined how inhibition of G9a, EZH2 or HDACs affects the expression of Kcna4, Kcnd2, Kcnq2 and Kcnma1 in the DRG. UNC0638 normalized mRNA levels for all four genes in the injured DRG ( Fig. 4a-d) . Treatment with SAHA restored the mRNA levels of Kcnd2, Kcnq2 and Kcnma1 only. GSK503 normalized levels of Kcnd2, Kcnq2 and Kcnma1 mRNA but decreased the Kcna4 mRNA level in the injured DRG (Fig. 4a-d) . We next sought to determine whether combining any two of the above inhibitors could produce greater effects on the genes encoding K + channels than any inhibitor alone. All three combination treatments caused much larger increases in the Kcnq2 mRNA levels in the injured DRG than did any of the npg a r t I C l e S inhibitors alone (Fig. 4c) . These results underscore the idea that histone modifications do not occur in isolation; rather, their combinatorial effects mediate the transcriptional signature of genes within the DRG. Additionally, UNC0638 treatment rescued the protein levels of all the four K + channels in the DRG reduced by SNL (Fig. 4e,f) . Because our ChIP-PCR and pharmacological studies highlighted a dominant role for G9a in nerve injury-induced silencing of genes encoding K + channels, we used a small interfering RNA (siRNA) targeting the G9a-encoding gene Ehmt2 to validate the results obtained with UNC0638. We confirmed the efficacy and specificity of the Ehmt2 siRNA in the DRG in rats (Fig. 4g,h ). Ehmt2-specific siRNA, but not control siRNA (universal negative control; Online Methods), normalized the levels of Kcna4, Kcnd2, Kcnq2 and Kcnma1 mRNA in the DRG of rats that underwent SNL (below referred to as SNL rats) (Fig. 4i) . However, treatment with Ehmt2-specific siRNA had no significant effect on the mRNA levels of the four K + channel genes in the DRG of rats that underwent sham surgery ('sham rats') ( Fig. 4j) . Together, these results indicate that increased G9a activity has an important function in the silencing of K + channel genes in the DRG by nerve injury.
G9a mediates nerve injury-induced reduction in Kv currents
We next conducted electrophysiological experiments to determine whether G9a inhibition could restore Kv currents in DRG neurons reduced by nerve injury. We performed whole-cell Kv recordings in acutely dissociated DRG neurons from sham control rats and SNL rats treated intrathecally with UNC0638 (10 µg per day) or vehicle for 8 d. K + channels encoded by Kcna4, Kcnd2, Kcnq2 and Kcnma1 are distributed in different types of DRG neurons 5, 7, [10] [11] [12] 21 . Because DRG neurons are highly heterogeneous, it was difficult to ensure that similar phenotypes of sensory neurons were sampled in the three groups. For this reason, we used isolectin B 4 (IB 4 )-conjugated Alexa Fluor 594, which can label a subgroup of live DRG neurons 10 . Double immunocytochemical analysis showed that SNL caused a 45% reduction in the number of IB 4 -positive neurons but did not change appreciably the distribution of cell sizes of IB 4 -labeled neurons in the DRG. UNC0638 treatment had no effect on the number and distribution of IB 4 -positive DRG neurons in SNL rats (Supplementary Fig. 6 ). The peak amplitudes of total, transient A-type and persistent non-A-type Kv currents of IB 4 -positive neurons were significantly lower in SNL rats than in control rats ( Fig. 5a-d) . Treatment with UNC0638 largely restored the total, A-type and non-A-type Kv currents of IB 4 -positive neurons in SNL rats ( Fig. 5a-d ). UNC0638 had no significant effect on voltage-dependent activation of Kv currents in these neurons. The V 0.5 values of total Kv currents (control, 31.1 ± 1.7 mV; SNL + vehicle, 33.0 ± 1.0 mV; SNL + UNC0638, 32.5 ± 1.2 mV), A-type Kv currents (control, 19.7 ± 3.2 mV; SNL + vehicle, 16.0 ± 5.3 mV; SNL+UNC0638, 16.8 ± 4.3 mV) and non-A-type Kv currents (control, 46.4 ± 1.3 mV; SNL + vehicle, 45.2 ± 1.0 mV; SNL + UNC0638, 45.9 ± 3.2 mV) were not significantly different between the three groups. There was no significant difference in the k value of total Kv currents (control, 24.6 ± 1.1 mV; SNL + vehicle, 22.3 ± 0.6 mV; SNL + UNC0638, 21.1 ± 0.8 mV), A-type Kv currents (control, 19.6 ± 1.9 mV; SNL + vehicle, 13.7 ± 1.3 mV; SNL + UNC0638, 15.1 ± 1.5 mV) and non-A-type Kv currents (control, 25.0 ± 0.5 mV; SNL + vehicle, 24.3 ± 0.4 mV; SNL + UNC0638, 24.7 ± 1.3 mV, mean ± s.e.m.) between the three groups ( Fig. 5e-g ). These results highlight the functional significance of increased G9a activity in diminished K + channel expression and activity of DRG neurons in neuropathic pain.
G9a is crucially involved in neuropathic pain development
To directly determine whether increased activity of G9a, EZH2 and HDACs is involved in neuropathic pain, we measured the effects of intrathecal injection of UNC0638, GSK503 and SAHA on pain hypersensitivity in SNL rats. Intrathecal administration of UNC0638 for 8 d gradually restored the nociceptive threshold to the baseline level (Fig. 6a) . UNC0638 also significantly attenuated tactile allodynia in SNL rats (P < 0.001; Fig. 6b ). Treatment with SAHA or GSK503 for 8 d (e-g) The conductance-voltage (G-V) curves of total and A-type Kv currents in DRG neurons from control and SNL rats treated with UNC0638 or vehicle. Data are mean ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001, compared with the corresponding value in the control group (two-way ANOVA). G/G max , normalized conductance. G max , maximal conductance. npg a r t I C l e S reduced hyperalgesia but had no effect on allodynia (Fig. 6a,b) . SAHA, UNC0638 and GSK503 had no significant effects on the nociceptive and tactile thresholds in sham rats (Supplementary Fig. 4g,h) .
We next determined whether any combination of the above inhibitors could produce a greater effect on pain hypersensitivity than any inhibitor alone. Only UNC0638 combined with SAHA fully restored the nociceptive and tactile thresholds of SNL rats to baseline levels ( Fig. 6c,d ). The effect of treatment with UNC0638 plus GSK503 was smaller than that of UNC0638 alone (Fig. 6a,c,d) .
We used the siRNA approach to validate our findings with the G9a inhibitor. Intrathecal treatment with Ehmt2-specific siRNA, but not control siRNA, significantly attenuated tactile allodynia (P = 0.0081, F 1,22 = 8.467) and mechanical hyperalgesia (P < 0.0001, F 1,22 = 31.82) of SNL rats (Fig. 6e,f) . Ehmt2-specific siRNA had no significant effect on the nociceptive (154.2 ± 7.4 versus 157.1 ± 4.7 g in control siRNA group, n = 12 rats, mean ± s.e.m.) or tactile (22.50 ± 1.7 versus 24.21 ± 1.1 g in control siRNA group, n = 12 rats) threshold of sham rats 3 weeks after surgery.
To validate the role of G9a in DRG neurons in diminished K + channel expression and pain hypersensitivity caused by nerve injury, we selectively deleted Ehmt2 in DRG neurons by crossing mice carrying a loxP-flanked Ehmt2 with a primary sensory neuron-specific Cre line (Avil Cre/+ ) 31 to create Ehmt2 conditional knockout (KO) mice. Conditional deletion of Ehmt2 was specific to the DRG and did not significantly alter baseline thermal and mechanical sensitivities (Fig. 7a,b) . In control mice (Ehmt2 flox/flox ;Avil +/+ ), spared nerve injury induced prolonged tactile allodynia and hyperalgesia (Fig. 7c,d ) and reduced levels of Kcna4, Kcnd2 and Kcnq2 mRNA in the DRG (Fig. 7e) . Notably, in Ehmt2 conditional KO mice, spared nerve injury failed to cause persistent pain hypersensitivity and reduction in the expression level of these K + channels in the DRG (Fig. 7c,d,f) . Collectively, our findings indicate that G9a in DRG neurons is critically involved in nerve injury-induced suppression of K + channel expression and in the transition from acute to chronic pain.
G9a inhibition normalizes genome-wide gene expression in the injured DRG To determine whether increased G9a activity contributes to the genome-wide effects of nerve injury on gene expression, we used RNA sequencing to analyze the mRNA profile in the DRGs obtained from sham (control) and SNL rats treated with UNC0638 or vehicle. We mapped the sequences obtained from this experiment to 16,811 different rat genes. The transcript values for UNC0638-treated SNL rats were closer to the values obtained from sham rats than those from SNL rats (Supplementary Fig. 7a) . From all the genes identified, 2,035 showed a change in expression values of at least twofold in the injured DRGs compared to the controls. Cluster analysis of expression values for this set of genes indicated that 832 were downregulated and 1,205 were upregulated. We performed ingenuity pathway analysis to identify canonical pathways in which these genes might have a role. Among the top ten, we identified pathways relevant to both neuronal regulation and inflammation (Supplementary Fig. 7b,c) .
Because the four K + channel genes selected for our study were all silenced by nerve injury (Fig. 1a) , we extended our analysis to the 105 K + channels mapped in our sequencing experiments, independently of the fold-change values. The heat map and dendrogram generated with the expression values for all the K + channels (including their auxiliary subunits) showed that the SNL samples clustered together and separated from the sham control. Moreover, UNC0638-treated SNL samples were closer to those from sham control rats than the vehicle-treated SNL rats were (Fig. 8a and Supplementary Table 2) . A total of 72 K + channel genes expressed at >1 fragments per kilobase of transcript Data are presented as mean ± s.e.m. *P < 0.05, **P < 0.01, ***P < 0.001, compared with the baseline control (a,b,e,f). # P < 0.05, ## P < 0.01, ### P < 0.001, compared with single inhibitor (c,d; symbols are color-coded to correspond to single inhibitor labels); statistical analysis was done by two-way ANOVA followed by Bonferroni post hoc tests. npg a r t I C l e S per million mapped reads, a threshold approximately equivalent to one copy per cell 32 . Remarkably, further analysis revealed that the expression of 42 K + channel genes was downregulated by nerve injury and that 40 (95.2%) of them were restored to levels close to that of the controls by UNC0638 treatment (Fig. 8b) . This result is in agreement with our ChIP-PCR data in which the repressive mark H3K9me2 was enriched at the promoter of four selected genes encoding K + channels after nerve injury (Fig. 3c-h) . When SNL rats were treated with UNC0638, G9a could not methylate H3K9; therefore the expression of suppressed genes was restored.
Because nerve injury-induced epigenetic silencing of K + channel expression in the DRG was due largely to increased G9a activity, we next asked what other genes behave similarly. We searched for genes whose expression levels changed at least twofold after nerve injury and for which, after UNC0638 treatment, the expression values were restored to levels comparable to that of the sham control. From the list of 2,035 genes that changed at least twofold in association with nerve injury, we identified 638 whose expression levels normalized to control values after UNC0638 treatment (Fig. 8c and Supplementary Table 3) . Notably, UNC0638 treatment not only restored those downregulated by nerve injury (n = 396 genes) but also normalized those upregulated by nerve injury (n = 242 genes) (Fig. 8c,d) . Ingenuity pathway analysis of these 638 genes revealed enrichment of genes involved in pain-related regulatory pathways (Fig. 8e) . These findings suggest that increased G9a activity is involved in altered expression of many genes associated with neuropathic pain and might be targeted for therapy.
DISCUSSION
A major knowledge gap in neuropathic pain research is whether epigenetic changes initiate and maintain abnormal gene expression in chronic pain induced by nerve injury. Many K + channels contribute to the regulation of the excitability of DRG neurons and pain hypersensitivity [10] [11] [12] 21, 33, 34 . Knockdown of the genes encoding Kv1.2 or Kv9.1 in naïve animals induces pain hypersensitivity 34, 35 , and overexpression of Kv1.2 or Kir2.1 reduces neuropathic pain 36, 37 . We found that nerve injury diminished K + channel expression within 3 weeks, a critical period during which acute pain transitions into its chronic phase in this rat model. Of note, nerve injury also progressively reduces the expression levels of other genes encoding voltagegated K + channels, such as Kcna2 (ref. 34) , Kcnd3 (ref. 38) and Kcns1 (ref. 35 ) in the DRG. We focused on analyzing K + channel expression in the injured L5 and L6 DRG, because only minor gene expression changes occur in the intact neighboring L4 DRG in SNL rats 3 . Our data suggest that dynamic downregulation of various types of K + channels in the DRG are involved in the initiation and maintenance of neuropathic pain through epigenetic reprogramming.
A salient finding of our study is that nerve injury consistently increased the repressive mark H3K9me2 occupancy at K + channel promoters in the DRG, which prompted our focus on G9a in this study. Although long noncoding RNA contributes to Kcna2 silencing in injured DRGs 34 , the roles of DNA methylation and histone modification in transcriptional silencing of K + channel expression in neuropathic pain had not been determined previously. H3K9 methylation is a highly conserved histone post-translational modification and is commonly linked to transcriptional repression. G9a and GLP are the primary enzymes for H3K9me2 (refs. 39,40) and exist predominantly as a G9a-GLP heteromeric complex that appears to be a functional H3K9 methyltransferase in vivo 41 . We found that nerve injury increased the global expression level and activity of G9a in the DRG. Furthermore, G9a inhibition restored the expression level of Kcna4, Kcnd2, Kcnq2 and Kcnma1 in injured DRGs, which is in agreement with the increased H3K9me2 enrichment at the promoter regions of these K + channel genes by nerve injury. In addition, we found that inhibiting G9a largely restored the Kv currents in DRG neurons diminished by nerve npg a r t I C l e S injury. These data provide functional evidence for the essential role of G9a-mediated histone modification in the transcriptional silencing of K + channel genes of DRG neurons in neuropathic pain.
We also provided evidence for the crucial role of G9a in nerve injury-induced chronic pain. Recent studies on epigenetic control of pain have been limited largely to HDACs. HDAC inhibitors can reduce pain hypersensitivity caused by tissue inflammation and nerve injury 42, 43 . Here we determined the relative contribution of G9a, EZH2 and HDACs to pain hypersensitivity caused by nerve injury. Compared with the effects of EZH2 and HDAC inhibitors, inhibiting G9a most effectively reversed pain hypersensitivity in SNL rats. We also found that treatment with Ehmt2-targeting siRNA fully restored the expression of Kcna4, Kcnd2, Kcnq2 and Kcnma1 in injured DRGs and largely attenuated pain hypersensitivity. In addition, nerve injury failed to reduce the expression of these K + channels in mice lacking G9a in DRG neurons. Our findings support the idea that increased G9a activity has a dominant function in neuropathic pain development. Nevertheless, it is difficult to determine to what extent the analgesic effect produced by G9a inhibition is attributable to its rescuing effect on K + channel expression. As shown by our RNA sequencing analysis, G9a inhibition restored the expression levels of many downregulated and upregulated genes that are involved in nociceptive signaling in the injured DRG; this restoration could also contribute to the analgesic effect of the G9a inhibitor. Regardless of the interpretations of the results, our study provides a new plausible mechanism underlying the analgesic effect of G9a inhibition on neuropathic pain. Because inhibition or knockdown of G9a had little effect on the K + channel expression or mechanical sensitivity in sham rats, the basal G9a activity in the normal DRG may be very low. It is not clear why siRNA knockdown inhibited G9a more effectively in injured DRGs than in control DRGs. Nerve injury upregulates large-pore pannexin-1 channels in the DRG 44 , which may increase the uptake of siRNA in injured DRGs. We found that G9a inhibition or Ehmt2 knockdown normalized hyperalgesia but only partially reduced tactile allodynia. Thus, G9a inhibition or Ehmt2 knockdown may rescue the expression of K + channels more in high-threshold nociceptive neurons than in low-threshold sensory neurons. Notably, mice with deletion of Ehmt2 in DRG neurons did not develop chronic pain, indicating that G9a in DRG neurons is the crucial epigenetic regulator involved in the transition from acute to chronic pain after nerve injury. npg a r t I C l e S Because nerve injury-induced changes in gene expression probably involve multiple epigenetic regulators, we explored potential interactions between G9a, HDACs and EZH2 in regulating K + channel expression and pain hypersensitivity. Notably, combined treatments with G9a and HDAC inhibitors produced significantly greater effects on K + channel expression levels and pain hypersensitivity than one inhibitor alone, suggesting a cooperative interaction between G9a and HDACs in the control of nerve injury-induced K + channel expression and neuropathic pain. This notion is supported by the findings that G9a inhibition not only reduced H3K9me2 levels but also increased H3K9ac levels 30 . The coordinated crosstalk between methylation and acetylation at H3K9 has been shown in other cells and tissues 45, 46 , which may explain why inhibition of methylation can lead to increased acetylation at H3K9. But the interaction between G9a and EZH2 seems to be complex. Combined treatments with G9a and EZH2 inhibitors produce a significantly smaller effect on pain hypersensitivity than the G9a inhibitor alone. Consistent with this finding, EZH2 inhibition further reduced the Kcna4 expression level in the injured DRG. Elucidating the integrated transcriptional network (i.e., co-repressors) involved in altered gene expression in neuropathic pain remains a challenging task.
Another major finding of our study is that G9a-mediated histone lysine methylation has a vital function in genome-wide gene-expression changes in the DRG caused by nerve injury. Nerve injury can cause upregulation and downregulation of thousands of genes, including those involved in axon regeneration, G protein signaling, immune responses, neurotrophins and ion channels in the DRG, as shown in our study and in previous reports 3, 4 . Notably, our RNA sequencing data show that inhibiting G9a activity restored almost all the silenced K + channel genes in injured DRGs. Moreover, G9a inhibition also normalized the expression levels of many other genes that are downregulated or upregulated after nerve injury. Many of these genes are related to serotonin receptors, calcium signaling, G protein-coupled receptors, axonal guidance and other signaling pathways known to be important in neuropathic pain and nociceptive regulations. Because G9a is generally known for mediating the H3K9me2 mark, which is associated with transcriptional repression, it was somewhat unexpected that G9a inhibition also normalized many upregulated genes in injured DRG. Some studies suggest that G9a may also function as a coactivator [47] [48] [49] . The dual activities of G9a as a repressor and activator may depend on its interacting partners 47 . Another possibility is that enrichment of H3K9me2 and G9a at the gene coding regions promotes active gene expression, in contrast to their transcriptional repressive function when present at gene promoters 49 . In addition, G9a may repress a transcriptional repressor for genes upregulated in injured DRGs. Our findings demonstrate that G9a has a critical function in the transcriptional repression and activation of a large number of genes associated with epigenetic plasticity in neuropathic pain.
Our study reveals an epigenetic mechanism for transcriptional gene silencing in neuropathic pain. Unlike previous studies focusing on one gene at a time, our study provides unique insight into the dominant role of G9a in a common shared mechanism for epigenetic silencing of almost all K + channels in the DRG in neuropathic pain. This knowledge advances our understanding of epigenetic plasticity involved in neuropathic pain development. G9a may represent a promising epigenetic target for preventing and treating chronic neuropathic pain.
METHODS
Methods and any associated references are available in the online version of the paper. 
ONLINE METHODS
Animal model of neuropathic pain and intrathecal cannulation. A total of 410 male Sprague-Dawley rats (8-9 weeks old; Harlan Sprague-Dawley, Indianapolis, IN) were used for this study. All animals were housed (2-3 rats per cage) in a standard 12:12 light-dark cycle with normal illumination. Spinal nerve ligation (SNL) in rats was used as the neuropathic pain model. Animals were anesthetized with 2-3% isoflurane, and the left L5 and L6 spinal nerves were isolated and ligated tightly with 6-0 silk suture under a surgical microscope, as described previously 22 . Age-matched sham-treated control rats were used as the control group. The sample sizes were determined on the basis of similar published studies using the same approaches. The surgical preparation and experimental protocols were approved by the Animal Care and Use Committee at The University of Texas MD Anderson Cancer Center and conformed to the US National Institutes of Health guidelines on the ethical care and use of animals.
To surgically implant an intrathecal catheter, we anesthetized rats with isoflurane and inserted PE-10 tubing through an incision made in the cisternal membrane. The catheter was advanced ~8 cm caudal so that the tip of each catheter was positioned at the lumbar spinal level. Rats displaying signs of motor or neurological dysfunction were excluded and killed immediately with an overdose of phenobarbital (200 mg per kg body weight (200 mg/kg), intraperitoneal (i.p.) injection). The animals were allowed to recover for 4-5 d before intrathecal injections. Drugs were injected intrathecally in a 5-µl volume, which was followed by a 10-µl flush with normal saline. Suberoxylanilide hydroxamic acid (SAHA; Sigma-Aldrich, St. Louis, MO) and UNC0638 (Sigma-Aldrich) were dissolved in dimethyl sulfoxide. GSK503 (GlaxoSmithKline Laboratories, Collegeville, PA) was dissolved in Captisol (Ligand Pharmaceuticals Inc., La Jolla, CA). The doses of these agents were selected on the basis of preliminary data and their effects on the activity of HDACs, G9a and EZH2. Drug treatment started 3 weeks after SNL, when chronic pain was well established.
A total of 46 mice were used in this study (8-10 weeks of age, males and females, sex and age matched). Wild-type mice with C57/BL6J genetic background were obtained from Jackson Laboratory (Bar Harbor, ME). We selectively deleted Ehmt2 (G9a) in DRG neurons by crossing mice carrying a loxP-flanked Ehmt2 (G9a flox/flox mice) with the primary sensory neuron-specific Cre line Avil Cre/+ (Advillin Cre/+ ) (ref. 31) to create conditional knockout (KO) mice. Male Advillin Cre/+ mice (from Duke University) were used to cross to female G9a flox/flox mice first to obtain male Advillin Cre/+ ;G9a flox/+ mice, which were crossed again to female G9a flox/flox mice to generate Advillin Cre/+ ;G9a flox/flox (G9a conditional KO, maintained on C57/BL6J genetic background) mice. Neuropathic pain was induced using the mouse spared nerve injury model (SNI) 50 . Briefly, mice were anesthetized with isoflurane, and an incision was made on the left lateral thigh to expose the sciatic nerve. We ligated and sectioned the common peroneal and tibial nerves (leaving the sural nerve intact) under a surgical microscope. The sham procedure consisted of the same surgery without nerve ligation and section.
Behavioral assessment of nociception. To quantify tactile allodynia, rats and mice were placed in individual plastic boxes on a mesh floor and allowed to acclimate for 30-45 min. A series of calibrated von Frey filaments was applied perpendicularly to the plantar surface of the hindpaw with sufficient force to bend the filaments for 6 s, and brisk paw withdrawals or flinching was considered as a positive response. In the absence of a response, the filament of next greater force was applied. If a response occurred, the filament of next lower force was applied. The tactile stimulus producing a 50% likelihood of withdrawal was determined using the 'up-down' calculation method 51 .
We measured mechanical hyperalgesia in nerve-injured animals by testing the withdrawal threshold in response to a noxious pressure stimulus (RandallSelitto test) using a paw-pressure analgesy meter (UgoBasile Biological Research, Comerio, Italy). When the animal displayed pain by either withdrawing the paw or vocalizing, the pedal was immediately released, and the nociceptive withdrawal threshold was read on the scale 6 . The investigator (G.L.) performing behavioral experiments was blinded to the treatments and the genotypes. All behavioral experiments were conducted between 10 a.m. and 5 p.m.
We quantified the heat and cold sensitivity in mice, as previously described 52 . The mice were placed in a Plexiglas cylinder on the metal plate and allowed to acclimate for 30 min. Using an incremental thermal plate (starting temperature 30 °C, ramp set at the maximum rate of 10 °C per minute; PE34, IITC Life Science, (TNT) buffer, rinsed in 0.1 M TBS, and blocked in 4% NSG in TBS for 1 h 54 . The sections were then incubated with the mixture of primary antibodies diluted in TBS solution containing 2% NGS and 0.3% Triton X-100 for 2 h at room temperature and overnight at 4 °C. Subsequently, sections were rinsed in TNT buffer and incubated with the secondary antibody mixture (Alexa Fluor-488 conjugated to goat anti-rabbit IgG, and Alexa Fluor 594 conjugated to goat anti-guinea pig IgG; dilution: 5 µg/ml) for 1.5 h. The sections were washed in TNT buffer three times and then rinsed in PBS for 30 min, mounted on slides, dried, and coverslipped. The sections were examined on a laser scanning confocal microscope (Zeiss, Germany). The antibodies used for immunocytochemistry were selected from previous publications: anti-G9a 55 Bisulfite sequencing and pyrosequencing. To investigate the methylation pattern of CpG sites near the transcriptional start site (TSS) of four K + channel genes, methylation data obtained from the L5 and L6 DRGs of control and SNL rats 3 weeks after surgery were compared. Genomic DNA obtained from pools of DRGs was treated with bisulfite using an Epitek bisulfite kit (Qiagen). This process converts the unmethylated cytosine to uracil but leaves the methylated cytosine unchanged. Using specific primers, the regions of interest close to the TSS of Kcna4, Kcnd2, Kcnq2, and Kcnma1 were amplified by PCR. The amplified DNA was cloned into 4-TOPO vector (Invitrogen), and the DNA obtained from individual clones after bacteria transformation was sequenced (Beckman Coulter Genomics). Each sequence, corresponding to a different allele, was analyzed for the presence of methylated cytosines using the QUMA web-based program (http://quma.cdb. riken.jp/). Primer sequences for bisulfite sequence are listed in Supplementary  Table 4 . Bisulfite-treated DNA obtained from the same samples was also analyzed by pyrosequencing technology using the PyroMarkQ24 platform (Qiagen).
digital restriction enzyme analysis of methylation (dReAm). DREAM analysis of K + channel genes was performed as described previously 59 . In brief, genomic DNA extracted from DRG samples was spiked with methylation standards and sequentially digested with two restriction endonucleases recognizing CCCGGG sites in DNA. SmaI cuts only unmethylated sites and leaves blunt ends. Next, XmaI cleaved the remaining methylated sites and leaves a 5′ overhang sequence. Thus, specific signatures were created for methylated and unmethylated sites. Enzyme-treated DNA was then used to generate sequencing libraries according to Illumina protocols and run on Illumina HiSeq 2000 and 2500 instruments. Sequencing data were mapped to the rat genome (version rn4, https://genome.ucsc.edu/cgi-bin/hgGateway?db=rn4) and the reads with unmethylated and methylated signatures were counted at individual CCCGGG sites. Methylation level was calculated as the ratio of reads with the methylated signature to all reads mapping to the site. chromatin immunoprecipitation PcR. We performed chromatin immunoprecipitation (ChIP) using the Magna ChIP G tissue kit (Millipore; catalog #17-20000), according to the manufacturer's instructions. Briefly, fresh DRG tissues were rapidly removed from anesthetized rats and were stabilized for 3 min using stabilization buffer. The DRGs were then incubated in 2% formaldehyde for 20 min at ~26 °C. After being washed three times with PBS, the DRGs were incubated in lysis buffer for 15 min on ice. Finally, the DRG tissues were sonicated (30 s on and 30 s off, repeated 200 times) in ChIP dilution buffer using a water bath sonicator (Qsonica, Newtown, CT) at 4 °C. The sonicated DRG samples were centrifuged at 12,000 r.p.m. for 10 min at 4 °C. Chromatin was pulled down using the following antibodies: IgG (as a negative control; catalog #ab124055, Abcam), total H3 (catalog #2650s, Cell Signaling Technology), H3K9me2 (catalog #ab1220, Abcam), H3K9ac (catalog #39917, Active Motif), H3K27me3 (catalog #9773s, Cell Signaling Technology), and H3K4me3 (catalog #9751s, Cell Signaling Technology). 5 µg of each antibody was used for ChIP. After chromatin precipitation, we performed quantitative PCR using the primers described in Supplementary Table 4 . Data were analyzed and corrected by input and total H3 conditions 60 .
RnA sequencing. DRG samples were obtained from four vehicle-treated SNL, three UNC0638-treated SNL and four sham-treated control rats. We generated strand-specific RNA libraries from 1 µg purified RNA using TruSeq stranded total RNA plus Ribo-zero kits (Illumina). Indexed libraries were normalized and pooled before sequencing. The sequencing was performed at the Genomics Facility, Fox Chase Cancer Center. Single end reads (50 bp, average 20 million reads) per sample were obtained using the HiSeq 2500 platform from Illumina. The sequencing reads were aligned to the rat genome rn4 using TopHat 61 , which takes into account reads coming from splicing junctions (parameters were set to default). The expression level of all RefSeq transcripts was evaluated using Cufflinks 62 , and a FPKM (fragments per kilobase of transcript per million fragments mapped) was calculated for each transcript (the parameters were set to default and the rn4 RefSeq GTF table was used to define the transcripts). We used principal component analysis (PCA) to test the correlation among the normalized sequencing data. Differences in gene-expression levels between samples were assessed with the Cuffdiff algorithm and calculated as log 2 (fold change). All the original RNA sequence data were deposited in the database repository of Gene Expression Omnibus (GEO GSE59043).
siRnA knockdown of Ehmt2. Three siRNA sequences targeting Ehmt2 (here referred to as G9a) and the universal negative control siRNA were purchased from Sigma-Aldrich (St. Louis, MO). We first validated and screened for the most effective G9a siRNA using the F11 DRG cell line, which was cultured in DMEM and 10% FBS (Invitrogen, Carlsbad, CA). Cells were plated at 55% confluency on the day of the transfection. The transfection reagent iFect (Neuromics, Edina, MN) was mixed with 2 µg of siRNA and incubated for 24 h at 37 °C. 48 h after transfection, the cells were harvested and the RNA was isolated. For determination of G9a knockdown efficiency, quantitative PCR was performed to measure the G9a mRNA levels using the F11 cell samples treated with the control siRNA and siRNAs targeting G9a. The siRNA sequence (AGUAACGGGCAUCAAUGC) that was the most effective in knocking down G9a was selected and used for the in vivo study.
On the day of injection, siRNA was mixed with iFect to a final concentration 400 mg/l according to the protocol for intrathecal injection 29 . The G9a-specific siRNA (4 µg) and the negative control siRNA were administered intrathecally for 4 consecutive days in SNL rats. The DRG neuronal uptake of siRNA delivered using iFect upon intrathecal injections has been shown previously 29 . 24 h after the last injection, the L5 and L6 DRGs were removed and used for PCR and western blot analyses.
dRg neuron dissociation and recording of k + channel currents. Rats were deeply anesthetized with 2-3% isoflurane, and the L5 and L6 DRGs were removed and immersed immediately into 1.5-ml sterile microcentrifuge tubes with 1 ml Hank's balanced salt solution (HBSS; pH 7.3-7.4). The attached nerve roots were trimmed, and the DRG neuronal dissociation was performed as previously described 63 . Briefly, the DRG tissue was incubated in 1 ml HBSS containing papain (75 units/ml, Worthington Biochemical Co., Lakewood, NJ) at 37 °C for 20 min. Then, the solution containing DRG tissues was centrifuged, and the solution was replaced with 1 ml HBSS containing type II collagenase (2,000 units/ml; Worthington Biochemical Co.) and type II dispase (5 units/ml; Roche Diagnostics, Indianapolis, IN) for another 20 min. After stopping the enzymatic digestion, complete F12 medium was used to resuspend the DRG neurons. A glass pipette was used for gentle trituration to separate the neurons, which were applied directly onto coverslips that had been incubated with poly-l-ornithine. The neurons were then kept in an incubator at 37 °C with 5% CO 2 for 2 h. The final recordings were performed 2-8 h after DRG dissociation.
The Kv currents of dissociated DRG neurons were recorded as described previously 5, 10 . The extracellular solution consisted of (in mM) 150 choline chloride, 5 KCl, 2 CaCl 2 , 1 MgCl 2 , 10 HEPES, 1 CdCl 2 , and 10 d-glucose (pH 7.4 adjusted with KOH, 320 mOsm). The glass recording pipettes were filled with an internal solution consisting of (in mM) 120 potassium gluconate, 20 KCl, 2 MgCl 2 , 10 EGTA, 10 HEPES, 5 Na 2 -ATP, and 1 CaCl 2 (pH 7.2, adjusted with KOH, 300 mOsm). Live DRG neurons were labeled in IB 4 -Alexa Fluor 594 (1:100; Invitrogen) solution for 1 min followed by a 2-min wash. IB 4 -positive neurons were visualized using epifluorescence and differential interference contrast optics on an inverted microscope (IX70, Olympus, Tokyo, Japan). The whole-cell recording (holding potential, −80 mV) was performed using EPC-10 amplifier and Pulse software (HEKA Instruments, Lambrect, Germany). The total whole-cell Kv current was recorded using a series of depolarizing voltages npg from −70 to 60 mV (400-ms pulse duration) in 10-mV increments at 2-s intervals 10 . In some neurons, the transient A-type Kv currents were isolated by using an A-type Kv channel blocker, 3,4-diaminopyridine (DAP) 5 . DAP-sensitive Atype Kv currents were derived by subtracting the Kv currents recorded in the presence of 5 mM DAP (i.e., DAP-insensitive persistent/non-A-type currents) from the baseline total Kv currents. Signals were filtered at 1 kHz and digitized at 10 kHz. The investigator (D.-P.L.) was blinded to the treatment groups during the recording experiments. data analysis and statistics. All data are presented as means ± s.e.m. The electrophysiological data were analyzed using the PulseFit software program (HEKA Instruments). The whole-cell current-voltage (I-V) curves for individual neurons were generated by calculating the peak outward current at each potential and normalizing to the cell capacitance. The conductance-voltage (G-V) curves were obtained with the Boltzmann equation: G/G max = 1/[1 + exp(V 0.5 -V m /k)], where V 0.5 is the membrane potential at which 50% activation is observed, k is the slope of the function, and V m is the membrane potential. To determine whether the treatment effects on mRNA and protein levels were statistically significant, we used the Mann-Whitney U-test to compare two groups and oneway ANOVA followed by Dunnett's or Tukey's post hoc test to compare more than two groups. Two-way ANOVA followed by Bonferroni post hoc test was used to determine significant differences between treatment effects on the K + channel currents and withdrawal thresholds. Pearson's correlation was used to determine the distance of clustered genes and similarities among samples. PCA was calculated by princomp function in R on the basis of correlation matrix, and PCA ellipse calculation, used to compare the clusters distance, was based on the square Mahalanobis distance metric 64 . Canonical pathway enrichment calculated with ingenuity pathways analysis is based on the right-tailed Fisher's exact test. P < 0.05 was considered statistically significant.
A Supplementary methods checklist is available.
